Table 2.

Impact of precise co-morbidities on the development of sepsis

Co-morbidity	Odds ratio	95% confidence intervals	p-value
Patients with acute pyelonephritis
Type 2 diabetes mellitus	1.31	1.02–1.68	0.033
Chronic heart failure	1.93	1.39–2.69	< 0.0001
Chronic renal disease	29.31	9.26–92.86	< 0.0001
Non-metastatic solid tumor malignancy	2.03	1.40–2.89	< 0.0001
Corticosteroid intake	2.08	1.08–3.98	0.028
Stroke	1.70	1.21–2.39	0.002
Dementia	1.97	1.37–2.84	< 0.0001
Patients with community-acquired pneumonia
Type 2 diabetes mellitus	1.73	1.06–2.82	0.027
Chronic heart failure	1.99	1.13–3.49	0.016
Coronary heart disease	3.72	1.69–8.19	0.001
Dementia	3.44	1.64–7.24	0.001
Patients with intraabdominal infections
Type 2 diabetes mellitus	3.29	2.15–5.03	< 0.0001
Chronic renal disease	26.77	3.51–204.37	0.002
Corticosteroid intake	3.86	1.41–10.53	0.008
Atrial fibrillation	2.73	1.41–5.28	0.003
Dementia	9.33	3.79–22.97	< 0.0001
Liver cirrhosis	9.16	1.06–79.53	0.044
Patients with primary bacteremia
Dementia	8.55	1.12–65.20	0.038

Only variables remaining significant after the final step of logistic forward conditional regression analysis are included